Ives Jeffrey L.'s Form 4 filing
Acumen Pharmaceuticals, Inc. (ABOS) · filed Aug 18, 2023
- Accession no.
- 0001576885-23-000052
- Filed
- Aug 18, 2023
- Trade date
- Aug 17, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $272.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ives Jeffrey L.CIK 0001614096 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2023 | Common Stock | MOption exerciseAcquired | +39,149 | $0.72 | +$28,187.28 | 39,149 | Direct | |
| Aug 17, 2023 | Common Stock | SSaleDisposed | −39,149 | $6.48 | −$253,685.52 | 0 | Direct | |
| Aug 17, 2023 | Common Stock | MOption exerciseAcquired | +2,800 | $1.19 | +$3,332 | 2,800 | Direct | |
| Aug 17, 2023 | Common Stock | SSaleDisposed | −2,800 | $6.66 | −$18,648 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2023 | Common Stock | MOption exerciseDisposed | −39,149 | $0.00 | $0 | 0 | Direct | |
| Aug 17, 2023 | Common Stock | MOption exerciseDisposed | −2,800 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.